Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PASG on Nasdaq
Shares outstanding
3,182,163
Price per share
$8.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
87,426
Total reported value
$702,031
Share change
-32,555,270
Value change
-$13,025,747
Number of holders
1
Price from insider filings
$8.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Erste Asset Management GmbH 4.4% -20% $810,414 -$166,650 2,455,800 -17% Erste Asset Management GmbH 31 Mar 2024
Lynx1 Capital Management LP 20% +31% $243,245 -$3,366,967 623,704 -93% LYNX1 CAPITAL MANAGEMENT LP 30 Sep 2025
ORBIMED ADVISORS LLC 4.2% -45% $53,029 -$44,595 132,473 -46% ORBIMED ADVISORS LLC 22 Jul 2025

As of 30 Sep 2025, 1 institutional investors reported holding 87,426 shares of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG). This represents 2.7% of the company’s total 3,182,163 outstanding shares.

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 87,426 $702,031 -$13,025,747 $8.03 1
2025 Q2 32,555,495 $13,025,837 -$494,591 $0.40 36
2025 Q1 36,319,532 $12,823,290 -$494,907 $0.35 40
2024 Q4 37,629,720 $21,576,538 -$666,122 $0.57 43
2024 Q3 38,667,152 $27,063,600 -$1,516,413 $0.70 43
2024 Q2 40,276,764 $31,993,150 -$250,391 $0.79 41
2024 Q1 40,302,560 $54,403,729 +$10,300,380 $1.35 47
2023 Q4 32,758,119 $33,084,893 +$1,665,873 $1.01 49
2023 Q3 32,389,479 $21,315,264 -$689,693 $0.66 48
2023 Q2 33,366,974 $31,393,818 -$2,067,482 $0.94 53
2023 Q1 35,544,402 $34,036,927 -$2,408,274 $0.96 55
2022 Q4 37,376,459 $51,570,790 -$593,641 $1.38 64
2022 Q3 1,232,073 $1,538,826 -$4,445,404 $1.42 8
2022 Q2 42,200,841 $99,586,412 -$2,254,627 $2.36 77
2022 Q1 42,974,148 $133,214,830 -$35,203,815 $3.10 99
2021 Q4 43,736,986 $277,681,358 -$20,365,609 $6.35 94
2021 Q3 42,080,753 $419,127,083 -$27,972,780 $9.96 98
2021 Q2 42,094,204 $557,333,406 -$6,360,822 $13.24 99
2021 Q1 44,993,194 $786,465,406 +$223,951,633 $17.48 88
2020 Q4 31,980,456 $817,765,848 +$41,938,422 $25.57 71
2020 Q3 30,776,051 $403,488,177 -$23,838,864 $13.11 68
2020 Q2 31,598,964 $862,660,732 +$80,586,836 $27.33 66
2020 Q1 29,151,958 $458,206,000 +$457,418,009 $15.75 45